Effect of Human Body Weight Changes on Circulating Levels of Peptide YY and Peptide YY3–36 | Zendy

Paul T. Pfluger | Zendy; J. Kampe | Zendy; Tamara R. Castañeda | Zendy; Torsten Vahl | Zendy; David A. D’Alessio | Zendy; Traci Kruthaupt | Zendy; S.C. Benoit | Zendy; Ulrich Cuntz | Zendy; H. Rochlitz | Zendy; M Moehlig | Zendy; A. Pfeiffer | Zendy; Corinna Koebnick | Zendy; Martin O. Weickert | Zendy; Barbara Otto | Zendy; J Spranger | Zendy; M. Tschöp | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Human Body Weight Changes on Circulating Levels of Peptide YY and Peptide YY3–36

Author(s) -

Paul T. Pfluger,

J. Kampe,

Tamara R. Castañeda,

Torsten Vahl,

David A. D’Alessio,

Traci Kruthaupt,

S.C. Benoit,

Ulrich Cuntz,

H. Rochlitz,

M Moehlig,

A. Pfeiffer,

Corinna Koebnick,

Martin O. Weickert,

Barbara Otto,

J Spranger,

M. Tschöp

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-1425

Subject(s) - peptide yy , anorectic , endocrinology , medicine , weight loss , obesity , hormone , body weight , neuropeptide , neuropeptide y receptor , receptor

Recent findings suggest that low plasma peptide YY (PYY) levels may contribute to diet-induced human obesity and justify PYY replacement therapy. Although the pharmacological value of PYY is controversial, further study of the secretion of the precursor PYY(1-36) and the pharmacologically active PYY(3-36) is indicated to determine the potential role in energy balance regulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research